Scutellarein inhibits hypoxia- and moderately-high glucose-induced proliferation and VEGF expression in human retinal endothelial cells

Acta Pharmacologica Sinica

Volumn 29, Issue 6, 2008, Pages 707-712

  Gao, Rong ^a   Zhu, Bang Hao ^a   Tang, Shi Bo ^b   Wang, Jiang Feng ^a   Ren, Jun ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF WYOMING   (United States)

Author keywords

Diabetic retinopathy; High glucose; Human retinal endothelial cells; Hypoxia; Scutellarein; Vascular endothelial growth factor

Indexed keywords

COBALT CHLORIDE; GLUCOSE; SCUTELLAREIN; VASCULOTROPIN;

ARTICLE; CELL ASSAY; CELL COUNT; CELL CULTURE; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PROTEIN EXPRESSION; RETINA CELL; WESTERN BLOTTING;

APIGENIN; CELL HYPOXIA; CELL PROLIFERATION; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 44849101717     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00797.x     Document Type: Article

References (24)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-de-pendent diabetes mellitus. N Engl J Med 1993 329:977 86.
2. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998 101:1219 24.
3. Kern TS, Engerman RL. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia. Arch Ophthalmol 1996 114:306 10.
4. Agardh CD, Agardh E, Zhang H, Ostenson CG. Altered endothelial/pericyte ratio in Goto-Kakizaki rat retina. J Diabetes Complications 1997 11:158 62.
5. Bursell SE, Takagi C, Clermont AC, Tagaki H, Mori F, Ishii H, et al. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. Invest Ophthalmol Vis Sci 1997 38:2711 20.
6. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999 48:1899 906.
7. Miller JW, Adamis AP, Aiello LP. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev 1997 13:37 50.
8. Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998 47:401 6.
9. Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, et al. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest 1998 78:1017 27.
10. Enaida H, Kabuyama Y, Oshima Y, Sakamoto T, Kato K, Kochi H, et al. VEGF-dependent signaling in retinal microvascular endothelial cells Fukushima. J Med Sci 1999 45:77 91.
11. Hata Y, Rook SL, Aiello LP. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes 1999 48:1145 55.
12. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995 113:1538 44.
13. Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K, Aiello LP, et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem 2000 275:40725 31.
14. Chen XQ, Jin YY. The new edition of medicaments. 14th ed. Beijing:People's Medical Publishing House 1997.
15. Wang GX. Pharmacologic action of breviscapine and clinic application. Lishizhen. Med Mater Med Res 1999 10:639 40.
16. Zhu BH, Guan YY, He H, Lin MJ. Erigeron breviscapus prevents defective endothelium-dependent relaxation in diabetic rat aorta. Life Sci 1999 65:1553 9.
17. Williams B, Gallacher B, Patel H, Orme C. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 1997 46:1497 503.
18. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996 98:2018 26.
19. Li B, Tang SB, Zhang G, Chen JH, Li BJ. Culture and characterization of human retinal capillary endothelial cell. Chin Ophthal Res 2005 23:20 2.
20. Premanand C, Rema M, Sameer MZ, Sujatha M, Balasubramanyam M. Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Invest Ophthalmol Vis Sci 2006 47:2179 84.
21. Berra E, Pages G, Pouyssegur J. MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 2000 19:139 45.
22. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992 255:989 91.
23. Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 1998 76:21 31.
24. Lee JW, Park JA, Kim SH, Seo JH, Lim KJ, Jeong JW, et al. Protein kinase C-θ regulates the stability of hypoxia-inducible factor-1α under hypoxia. Cancer Sci 2007 98:1476 81.